Trial Profile
An Open Label Trial of Milnacipran in the Treatment of Women With Provoked Vestibulodynia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Feb 2023
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Vulvodynia
- Focus Proof of concept; Therapeutic Use
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2012 Planned end date changed from 1 Oct 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 19 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.